Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now official registry

Spasticity, Muscle clinical trials

Every US clinical trial registered for Spasticity, Muscle — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.

12 US clinical trials · 7 currently recruiting

The research picture

Spasticity, Muscle has 12 registered US clinical trials, 7 of them open to new participants right now — about 58% of the total.

7
recruiting participants now
58%
of trials open to enrollment
1
in Phase 3–4 (later-stage)
2
top sponsor: Medical University of South Carolina

Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.

Active & Recent Trials

RECRUITING 200 participants

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

Boston Children's Hospital

NCT05354622

RECRUITING NA 30 participants

Extracorporeal Shockwave Therapy for Spasticity in People With Spinal Cord Injury

Kessler Foundation

NCT05432999

RECRUITING NA 28 participants

Activating Spinal Circuits to Improve Walking, Balance, Strength, and Reduce Spasticity

Shepherd Center, Atlanta GA

NCT05429736

RECRUITING NA 25 participants

Operant Conditioning of Spinal Reflexes Training System--Reflex Operant Down Conditioning

Medical University of South Carolina

NCT05094362

RECRUITING NA 22 participants

Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy

Ohio State University

NCT06070233

RECRUITING NA 12 participants

Transcutaneous Spinal Stimulation for Lower Limb Spasticity in Spinal Cord Injury

University of Mississippi Medical Center

NCT05457205

RECRUITING Phase 1 4 participants

Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimized Human AP4M1 Transgene (hAP4M1opt)

Elpida Therapeutics SPC

NCT05518188

COMPLETED Phase 3 323 participants

A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MS

RVL Pharmaceuticals

NCT03319732

COMPLETED 105 participants

Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin

University of Texas Southwestern Medical Center

NCT05103202

COMPLETED 60 participants

Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity

Vanderbilt University Medical Center

NCT03209960

COMPLETED 60 participants

Using Telemedicine to Improve Spasticity Diagnosis Rates

Vanderbilt University Medical Center

NCT03211390

COMPLETED NA 11 participants

DDN in Stroke--COBRE

Medical University of South Carolina

NCT05196737

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 3 1

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Spasticity, Muscle Trial Landscape

ClinicalTrials.gov lists 12 US studies indexed under Spasticity, Muscle, and 7 of those are currently open to recruitment — roughly 58% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Spasticity, Muscle shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Spasticity, Muscle is led by Medical University of South Carolina with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 12 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Spasticity, Muscle?

PlainTrial tracks 12 US clinical trials for Spasticity, Muscle, of which 7 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Spasticity, Muscle?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →